3,4-dihydroxyphenylacetic acid has been researched along with 1,3-ditolylguanidine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HS; Lehmann, J; Martin, LL; Rao, TS; Wood, PL | 1 |
| Beart, PM; Manallack, DT; O'Shea, RD | 1 |
| Bastianetto, S; Perrault, G; Rouquier, L; Sanger, DJ | 1 |
| Matsunaga, KH; Matsuno, K; Mita, S | 1 |
| Lockwood, M; Patrick, RL; Patrick, SL; Perkel, JM; Walker, JM | 1 |
| Cagnotto, A; De Deurwaerdère, P; Marrazzo, A; Mennini, T; Moison, D; Prezzavento, O; Ronsisvalle, G; Spampinato, U | 1 |
6 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1,3-ditolylguanidine
| Article | Year |
|---|---|
Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Carbazoles; Cerebral Cortex; Dibenzocycloheptenes; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Guanidines; Ligands; Male; Neural Pathways; Pipecolic Acids; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Phencyclidine; Stereoisomerism | 1990 |
Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Brain; Carbazoles; Cyclazocine; Dopamine; Dopamine Agents; GTP-Binding Proteins; Guanidines; Guanosine Triphosphate; Magnesium; Male; Phenazocine; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma | 1989 |
DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigro-striatal dopaminergic pathways.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Dopamine; Dopamine D2 Receptor Antagonists; Extracellular Space; Guanidines; Homovanillic Acid; Male; Microdialysis; Neostriatum; Neural Pathways; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, sigma; Stereotyped Behavior; Substantia Nigra | 1995 |
Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Antipsychotic Agents; Carbazoles; Corpus Striatum; Extracellular Space; Frontal Lobe; Guanidines; Kinetics; Ligands; Male; Microdialysis; Pentazocine; Phenazocine; Piperidines; Rats; Rats, Wistar; Receptors, sigma; Time Factors | 1995 |
Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Guanidines; Homovanillic Acid; Male; Pentazocine; Rats; Rats, Sprague-Dawley; Receptors, sigma; Stereotyped Behavior | 1993 |
Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Cyclopropanes; Dopamine; Dopamine Antagonists; Guanidines; Guinea Pigs; Haloperidol; In Vitro Techniques; Male; Microinjections; Neostriatum; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, sigma | 2003 |